Skip to main content
Watch Insiders
SEPN filings

Corporate insider profile

Peter Kolchinsky Filing Activity

Latest reported as Corporate insider of Septerna, Inc. (SEPN).

Purchase filings
16
Reported companies
6
Net open-market value
$489,691,730
Latest transaction
Aug 12, 2026

Affiliated corporations

Reported company relationships

SEPNLatest reported

Septerna, Inc.

Corporate insider

ARTVPrior filing

Artiva Biotherapeutics, Inc.

Corporate insider

PBLSPrior filing

Parabilis Medicines, Inc.

Corporate insider

VORPrior filing

Vor Biopharma Inc.

Corporate insider

HOWLPrior filing

Werewolf Therapeutics, Inc.

Corporate insider

COAGPrior filing

Hemab Therapeutics Holdings, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 12, 2026Septerna, Inc. (SEPN)Corporate insiderSale1,493,000$42.50$63,452,500
Jul 31, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase45,768$9.96$455,726
Jul 24, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase41,319$9.99$412,777
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium